Xolair

In the US, Xolair (omalizumab systemic) is a member of the drug class other immunosuppressants and is used to treat Asthma, Maintenance.

US matches:

• Xolair

UK matches:

• Xolair 150 mg powder and solvent for solution for injection
• Xolair 150 mg powder and solvent for solution for injection (SPC)

Ingredient matches for Xolair

Omalizumab

Omalizumab is reported as an ingredient of Xolair in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Brazil


• Canada


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Hong Kong


• Hungary


• Ireland


• Israel


• Japan


• Mexico


• Netherlands


• New Zealand


• Norway


• Poland


• Portugal


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.